º£½ÇÉçÇøapp

Construction Contract Leads

Section I: Contracting authority

I.1) Name and addresses

PIRBRIGHT INNOVATIONS LIMITED

Pirbright

WOKING

GU240NF

Email

procurement [at] pirbrightinnovations.co.uk

Country

United Kingdom

NUTS code

UKJ25 - West Surrey

Companies House

04394007

Internet address(es)

Main address

I.3) Communication

Access to the procurement documents is restricted. Further information can be obtained at

Additional information can be obtained from the above-mentioned address

Tenders or requests to participate must be submitted electronically via

I.4) Type of the contracting authority

Other type

Institute

I.5) Main activity

Other activity

Animal Research

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

The Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) - Design and Build

Reference number

CVIM/D&B/2024

II.1.2) Main CPV code

• 45214610 - Laboratory building construction work

II.1.3) Type of contract

Works

II.1.4) Short description

A joint initiative between the Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation (UKRI), the Foreign, Commonwealth and Development Office (FCDO) and the Bill & Melinda Gates Foundation will see the creation of a new centre at The Pirbright Institute designed to accelerate the development of animal vaccines to combat emerging and urgent infectious diseases.

The consequences of livestock disease can be catastrophic. As well as posing a very real risk to global food security and international trade, livestock disease also presents a significant threat to global human health due to its pandemic potential.

While the UK remains a world-leader in the early-stage development of vaccines for both human and veterinary medicine, globally we need to strengthen our collective capacity to translate scientific discoveries into solutions for the most challenging veterinary infectious diseases.

The new Centre for Veterinary Vaccine Innovation and Manufacturing (CVIM) will bridge the gaps between research and expertise in process development and manufacturing while strengthening the UK's own emergency response capacity and capability. It will bring about tangible health and economic benefits by focusing on diseases prevalent in low- and middle-income countries.

II.1.5) Estimated total value

Value excluding VAT: £6,500,000

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.3) Place of performance

NUTS codes

• UKJ25 - West Surrey

II.2.4) Description of the procurement

Procurement Route - Design and Build

Tender Strategy - 'Open Procedure' Single Stage Tender

Design Stage - Stage 3

Form of Contract - NEC4 Option A: Fixed Price with Activity Schedule

The successful Contractor will be responsible for designing and building a c.590m2 new-build facility for The Pirbright Institute, c.461m2 of functional space on the ground floor and c.129m2 of plant space on the first floor.

1) General building outline: New build facility, 590m2, two story above ground, with all functions on ground floor, and plant room on the first floor, comprising of 1 nr GMP cleanroom (ISO007), 1 nr cold-room (CNC), 1 nr freezer room, RM Storage and receipt areas, 1 nr QC Micro lab (CNC), 1 nr QC lab (CNC), a write up area/office and all supporting areas including a plant room and associated external works.

2) The building will be constructed within the existing Pirbright site.

3) Achieve Part L - 2, target for Net Zero Carbon (NZC).

The design of the facility will include biocontainment (ACDP CL2/SAPO2/GMO2), BREEAM: Very Good, cleanrooms (up to ISO7), good manufacturing practice (GMP), net-zero carbon and equity, diversity and inclusion (EDI). The project team that developed the RIBA Stage 3 design in conjunction with the end-user requirements were as follows.:

• Project Manager - Currie and Brown

• Cost Manager - Turner and Townsend

• Multi-Disciplinary Design Consultant / CMT - Scitech

Following the publication of F01: Prior information notice (PIN) 2023/S 000-013633 on 12th May 2023 which was published to establish interest within the market and to help inform us on a number of strategic decisions in relation to this procurement, and determine our strategy a second PIN 2024/S 000-002555 was published on 25th January 2024 to advise of the planned future procurement. We have determined that a Design and Build, 'Open Procedure' Single Stage Tender offers the quickest route to completion whilst still meeting competition.

Along with this F02: Contract Notice a Contracts Finder Notice will be published on the same day and referenced in VI.3 Additional information of this F02: Contracts Notice (see below). With the ITT (Invitation to Tender) Pack or a least some of it being upload as attachments on to the Contracts Finder Notice (the remaining Appendix/documents will be available on receipt of a completed and signed of a Confidentiality Agreement see in VI.3 Additional information below. The ITT package will also be available on demand from procurement [at] pirbrightinnovations.co.uk. The RIBA stage 3 information will be included in the ITT pack. The Contractor will tender the works on an RIBA Stage 3 design which will form part of the contract documentation, the Contractor as part of their contractual obligations shall further develop the design making design submissions post-contract for approval by the Project Manager and the compliance monitoring team.

The contract proposed is NEC4 Option A: Fixed Price with Activity Schedule with 'Z Clauses' that will be included in 'draft' as part of the ITT pack.

The 'desired' completion date is January 2026. At this point, a planning consultant has been engaged but the project is still subject to a planning submission and approval - the Contractor would be responsible for discharging residual planning conditions as required. The Contractor shall also be responsible for discharging residual BREEAM conditions (will be included within tender pack) and taking on the net-zero carbon philosophy received to completion.

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months

18

This contract is subject to renewal

No

II.2.10) Information about variants

Variants will be accepted: Yes

II.2.11) Information about options

Options: No

Section IV. Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

IV.2) Administrative information

IV.2.2) Time limit for receipt of tenders or requests to participate

Date

5 July 2024

Local time

12:00pm

IV.2.4) Languages in which tenders or requests to participate may be submitted

English

IV.2.7) Conditions for opening of tenders

Date

5 July 2024

Local time

2:00pm

Section VI. Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: No

VI.3) Additional information

This requirement has also been advertised on Contracts Finder.

The ITT package can be found on Contracts Finder or on request from procurement [at] pirbrightinnovations.co.uk

Please note that Appendix 1 - Confidentiality Agreement must be completed, signed, and emailed to procurement [at] pirbrightinnovations.co.uk asap. Then and only then will access to the full ITT package (Appendices 4 & 5) be granted to the requester.

VI.4) Procedures for review

VI.4.1) Review body

Pirbright Innovations Ltd

Pirbright

Country

United Kingdom